Literature DB >> 12907679

Structure-function analysis of the bestrophin family of anion channels.

Takashi Tsunenari1, Hui Sun, John Williams, Hugh Cahill, Philip Smallwood, King-Wai Yau, Jeremy Nathans.   

Abstract

The bestrophins are a newly described family of anion channels unrelated in primary sequence to any previously characterized channel proteins. The human genome codes for four bestrophins, each of which confers a distinctive plasma membrane conductance on transfected 293 cells. Extracellular treatment with methanethiosulfonate ethyltrimethylammonium (MTSET) of a series of substitution mutants that eliminate one or more cysteines from human bestrophin1 demonstrates that cysteine 69 is the single endogenous cysteine responsible for MTSET inhibition of whole-cell current. Cysteines introduced between positions 78-99 and 223-226 are also accessible to external MTSET, with MTSET modification at positions 79, 80, 83, and 90 producing a 2-6-fold increase in whole-cell current. The latter set of four cysteine-substitution mutants define a region that appears to mediate allosteric control of channel activity. Mapping of transmembrane topography by insertion of N-linked glycosylation sites and tobacco etch virus protease cleavage sites provides evidence for cytosolic N and C termini and an unexpected transmembrane topography with at least three extracellular loops that include positions 60-63, 212-227, and 261-267. These experiments provide the first structural analysis of the bestrophin channel family.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907679      PMCID: PMC2885917          DOI: 10.1074/jbc.M306150200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity.

Authors:  Raimund Dutzler; Ernest B Campbell; Martine Cadene; Brian T Chait; Roderick MacKinnon
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

2.  A novel method to determine the topology of peroxisomal membrane proteins in vivo using the tobacco etch virus protease.

Authors:  K N Faber; A M Kram; M Ehrmann; M Veenhuis
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

Review 3.  From stones to bones: the biology of ClC chloride channels.

Authors:  A L George; L Bianchi; E M Link; C G Vanoye
Journal:  Curr Biol       Date:  2001-08-07       Impact factor: 10.834

4.  The HMMTOP transmembrane topology prediction server.

Authors:  G E Tusnády; I Simon
Journal:  Bioinformatics       Date:  2001-09       Impact factor: 6.937

Review 5.  Quality control in the endoplasmic reticulum.

Authors:  Lars Ellgaard; Ari Helenius
Journal:  Nat Rev Mol Cell Biol       Date:  2003-03       Impact factor: 94.444

Review 6.  Mannose 6-phosphate receptors: new twists in the tale.

Authors:  Pradipta Ghosh; Nancy M Dahms; Stuart Kornfeld
Journal:  Nat Rev Mol Cell Biol       Date:  2003-03       Impact factor: 94.444

7.  A biological role for prokaryotic ClC chloride channels.

Authors:  Ramkumar Iyer; Tina M Iverson; Alessio Accardi; Christopher Miller
Journal:  Nature       Date:  2002-10-17       Impact factor: 49.962

Review 8.  The voltage-gated potassium channels and their relatives.

Authors:  Gary Yellen
Journal:  Nature       Date:  2002-09-05       Impact factor: 49.962

9.  The vitelliform macular dystrophy protein defines a new family of chloride channels.

Authors:  Hui Sun; Takashi Tsunenari; King-Wai Yau; Jeremy Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

10.  Large-scale purification of a stable form of recombinant tobacco etch virus protease.

Authors:  L J Lucast; R T Batey; J A Doudna
Journal:  Biotechniques       Date:  2001-03       Impact factor: 1.993

View more
  105 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXXV: calcium-activated chloride channels.

Authors:  Fen Huang; Xiuming Wong; Lily Y Jan
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

2.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

Review 3.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

Review 4.  [Morbus Best].

Authors:  O Strauss
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

5.  Distribution of cGMP-dependent and cGMP-independent Ca(2+)-activated Cl(-) conductances in smooth muscle cells from different vascular beds and colon.

Authors:  Vladimir V Matchkov; Christian Aalkjaer; Holger Nilsson
Journal:  Pflugers Arch       Date:  2005-06-17       Impact factor: 3.657

Review 6.  Role of kidney chloride channels in health and disease.

Authors:  I Elias Veizis; Calvin U Cotton
Journal:  Pediatr Nephrol       Date:  2006-11-16       Impact factor: 3.714

7.  Molecular consequences of BEST1 gene mutations in canine multifocal retinopathy predict functional implications for human bestrophinopathies.

Authors:  Karina E Guziewicz; Julianna Slavik; Sarah J P Lindauer; Gustavo D Aguirre; Barbara Zangerl
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-23       Impact factor: 4.799

8.  Bestrophin expression and function in the human pancreatic duct cell line, CFPAC-1.

Authors:  Laura L Marsey; John P Winpenny
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

9.  Rescue of volume-regulated anion current by bestrophin mutants with altered charge selectivity.

Authors:  Li-Ting Chien; H Criss Hartzell
Journal:  J Gen Physiol       Date:  2008-11       Impact factor: 4.086

10.  Bestrophin-2 is involved in the generation of intraocular pressure.

Authors:  Benjamin Bakall; Precious McLaughlin; J Brett Stanton; Youwen Zhang; H Criss Hartzell; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.